Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.

Abstract:

:Parkinson's disease and Alzheimer's disease are the most common neurodegenerative diseases in the elderly population. Given that age is the most important risk factor in these diseases, the number of patients is expected to rise dramatically in the coming years. Therefore, an effective therapy for these diseases is highly sought. Current treatment brings only temporary symptomatic relief and does not result in halting the progression of these diseases. The increasing knowledge on the molecular mechanisms that underlie these diseases enables the design of novel therapies, targeted at degenerating neurons by creating an optimal regenerative cellular environment. Here, we review the progress made in the field of cell-replacement and gene-therapy strategies. New developments in the application of embryonic stem cells and adult neuronal progenitors are discussed. We also discuss the use of genetically engineered cells in neuronal rescuing strategies that have recently advanced into the clinic. The first trials for the treatment of Alzheimer's disease and Parkinson's disease with this approach are ongoing.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Korecka JA,Verhaagen J,Hol EM

doi

10.2217/17460751.2.4.425

subject

Has Abstract

pub_date

2007-07-01 00:00:00

pages

425-46

issue

4

eissn

1746-0751

issn

1746-076X

journal_volume

2

pub_type

杂志文章,评审
  • Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.

    abstract::A major challenge to commercializing cell-based therapies is developing scalable manufacturing processes while maintaining the critical quality parameters (identity, potency, purity, safety) of the final live cell product. Process development activities such as extended passaging and serum reduction/elimination can fa...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.105

    authors: Carmen J,Burger SR,McCaman M,Rowley JA

    更新日期:2012-01-01 00:00:00

  • Biochemical characterization of pure dehydrated binate amniotic membrane: role of cytokines in the spotlight.

    abstract:AIM:Placental allografts used for tissue regeneration differ in membrane compositions and processing techniques. A uniquely folded dehydrated binate amniotic membrane (DBAM) was biochemically characterized to evaluate its potential role in wound healing. METHODS:Histology, Luminex-based immunoassay and standard in vit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0085

    authors: Sane MS,Misra N,Quintanar NM,Jones CD,Mustafi SB

    更新日期:2018-09-01 00:00:00

  • Short-term outcomes after pure bone marrow aspirate injection for severe knee osteoarthritis: a case series.

    abstract::Background: Bone marrow aspiration (BMA) is among a group of autologous cell-based therapies currently being explored to treat osteoarthritis (OA). Materials & methods: This retrospective case study observed ten patients (13 knees) with severe knee OA who failed extensive conservative treatment and were treated with B...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0113

    authors: Colberg RE,Jurado Vélez JA,Walsh KP,Fleisig G

    更新日期:2020-07-01 00:00:00

  • Cellular replacement and regenerative medicine therapies in ischemic stroke.

    abstract::Worldwide, tissue engineering and cellular replacement therapies are at the forefront of the regenerative medicine agenda, and researchers are addressing key diseases, including diabetes, stroke and neurological disorders. It is becoming evident that neurological cell therapy is a necessarily complex endeavor. The bra...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.2

    authors: Thwaites JW,Reebye V,Mintz P,Levicar N,Habib N

    更新日期:2012-05-01 00:00:00

  • Clinical use of autologous micro-fragmented fat progressively restores pain and function in shoulder osteoarthritis.

    abstract::Aim: We aim to show that the use of nondigested micro-fragmented adipose tissue (MFat™, Lipogems®) is a viable alternative for treatment of joint pain and inflammation associated dysfunction in shoulder osteoarthritis (OA). Materials & methods: A total of 25 subjects with OA received an injection of MFat™ and were fol...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0069

    authors: Vinet-Jones H,F Darr K

    更新日期:2020-10-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • Endotoxin-induced silencing of mesoderm induction and functional differentiation: role of HMGB1 in pluripotency and infection.

    abstract:OBJECTIVES:Mechanisms underpinning Gram-negative bacterial vaginosis-induced birth anomalies are obscure. Ethical issues limit such studies on peri-implantation-stage human embryos. Here we have used embryoid bodies (EBs) as an in vitro model to examine the effect of Gram-negative bacterial endotoxins/lipopolysaccharid...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.3.1.23

    authors: Sivasubramaniyan K,Atluri RR,Sarda K,Arvind M,Balaji V,Deb KD

    更新日期:2008-01-01 00:00:00

  • Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.

    abstract::Induced pluripotent stem (iPS) cells offer tremendous opportunity for the creation of autologous cellular therapies, in which gene correction or the avoidance of immune response issues are desirable. In addition, iPS cells avoid the ethical concerns raised by the sourcing of human embryonic stem cells (hESCs) from emb...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.55

    authors: Carpenter MK,Couture LA

    更新日期:2010-07-01 00:00:00

  • From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes.

    abstract::Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational intere...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.70

    authors: Ricordi C,Inverardi L,Domínguez-Bendala J

    更新日期:2012-11-01 00:00:00

  • Chronic ischial tuberosity avulsion nonunion fracture treated with a platelet-rich plasma injection as a bone graft.

    abstract::We present a case of an 18-year-old with a 2-year history of buttock pain who failed extensive treatment for a perceived hamstring strain. Upon evaluation, he was diagnosed with an ischial tuberosity nonunion avulsion fracture. The patient underwent bone grafting via an ultrasound guided leukocyte rich platelet-rich p...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0071

    authors: Stafford CD 2nd,Colberg RE,Nourse AL

    更新日期:2019-05-01 00:00:00

  • Enhancing medial layer recellularization of tissue-engineered blood vessels using radial microchannels.

    abstract::Aim: Cell repopulation of tissue-engineered vascular grafts (TEVGs) from decellularized arterial scaffolds is limited by dense concentric tunica media layers which impede cells migrating radially between the layers. We aimed to develop and validate a new microneedle device to modify decellularized carotid arteries wit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0011

    authors: Eufrásio-da-Silva T,Ruiz-Hernandez E,O'Dwyer J,Picazo-Frutos D,Duffy GP,Murphy BP

    更新日期:2019-11-01 00:00:00

  • Company profile: Sistemic Ltd.

    abstract::Founded in 2009 and headquartered in Glasgow, Scotland, UK, Sistemic Ltd has developed from a thought in the minds of four scientists into a company working globally to play its part in delivering the exciting opportunities for improvements in human health presented by cell therapies and regenerative medicine products...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.58

    authors: Reid J

    更新日期:2013-09-01 00:00:00

  • Safety and efficacy of cell therapies administered in the acute and subacute stages after stroke: a meta-analysis.

    abstract:AIMS:To evaluate the safety and efficacy of cell therapies administered acutely/sub-acutely after stroke. METHODS:Five databases were searched for studies examining the safety/efficacy of cell therapies administered ≤90 days post-stroke. Reporting quality and adherence to research guidelines were evaluated. Safety and...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.2217/rme-2016-0063

    authors: Unsworth DJ,Mathias JL,Dorstyn DS

    更新日期:2016-10-01 00:00:00

  • Genzyme: 15 years of cell and gene therapy research.

    abstract::Finding solutions for patients with unmet needs is at the heart of Genzyme's innovative medical research. While small molecules and enzyme-replacement therapies have made significant strides in improving patients' quality of life and expectancy, the solutions to many conditions, such as heart disease or CNS diseases, ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.1.95

    authors: De Bie C

    更新日期:2007-01-01 00:00:00

  • Interview: Discussions on the development of human embryonic stem cell-based therapies.

    abstract::Dr Jane Lebkowski joined Geron Corporation in 1998 and is currently Senior Vice President and Chief Scientific Officer of the Regenerative Medicine Division. Dr Lebkowski heads Geron's human embryonic stem cell program, and is responsible for all research, preclinical development, product development, manufacturing an...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.49

    authors: Lebkowski JS

    更新日期:2009-09-01 00:00:00

  • Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.

    abstract::Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0065

    authors: Chan S

    更新日期:2017-10-01 00:00:00

  • Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease.

    abstract:AIMS:Therapeutic replacement of organs with healthy cells requires disease-specific strategies. As copper toxicosis due to ATP7B deficiency in Wilson disease produces significant liver injury, disease-specific study of transplanted cell proliferation will offer insights into cell and gene therapy mechanisms. MATERIALS...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.3.2.165

    authors: Malhi H,Joseph B,Schilsky ML,Gupta S

    更新日期:2008-03-01 00:00:00

  • The role of policies and networks in development of cord blood usage in China.

    abstract::Research regarding the use of cord blood (CB) has focused on antigen match and the number of stem cells, with policies and networks related to its use being under researched. This article is based on fieldwork in China from 2013 to 2015 and examines ways that the studied CB bank enhances CB usage in China. This articl...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0050

    authors: Chang HC

    更新日期:2017-09-01 00:00:00

  • Cognitive regeneration or enhancement: the ethical issues.

    abstract::The neurological and physiological basis of brain function and disease has been a significant focus of investigation throughout the history of medical research. Recent advances in understanding have led to the development of new treatments for diseases of the brain and defects of cognitive and behavioral function: pha...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.3.361

    authors: Chan S,Harris J

    更新日期:2006-05-01 00:00:00

  • Fibrin hydrogels to deliver dental stem cells of the apical papilla for regenerative medicine.

    abstract:AIM:Evaluation of survival, proliferation and neurodifferentiation of dental stem cells from the apical papilla (SCAP) in fibrin hydrogels. We hypothesized that fibrin composition will influence cell behavior. METHODS:Modulus, pore and fiber size were measured. SCAP in vitro viability, proliferation and neural differe...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.81

    authors: Germain L,De Berdt P,Vanacker J,Leprince J,Diogenes A,Jacobs D,Vandermeulen G,Bouzin C,Préat V,Dupont-Gillain C,des Rieux A

    更新日期:2015-01-01 00:00:00

  • Graft and host interactions following transplantation of neural stem cells to organotypic striatal cultures.

    abstract:AIMS:To investigate neural stem cell (NSC) interactions with striatal tissue following engraftment and the effects of growth factors. MATERIALS & METHODS:Organotypic striatal slice cultures established from neonatal rats were used as an ex vivo model system. Survival, integration and differentiation of grafted NSCs fr...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.80

    authors: Jäderstad LM,Jäderstad J,Herlenius E

    更新日期:2010-11-01 00:00:00

  • Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation.

    abstract::Background: To evaluate whether subtenon injection of platelet-rich plasma (PRP) with retinal electromagnetic stimulation (rEMS) is effective in therapy-resistant chronic central serous chorioretinopathy (CSCR). Design: Prospective, sequential. Materials & methods: The study included 22 eyes with resistant chronic CSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0056

    authors: Arslan U,Özmert E

    更新日期:2020-08-01 00:00:00

  • Biocompatibility and the efficacy of medical implants.

    abstract::Biocompatibility is key to the performance of any material in a biological environment. This review outlines current opinion on the factors that lead to biocompatibility and focuses on the interactions that occur at the interface between material and environment. The sequence of events, from protein adsorption, cell a...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.1.6.789

    authors: Shard AG,Tomlins PE

    更新日期:2006-11-01 00:00:00

  • Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

    abstract:AIM:To evaluate the in vitro immunogenic and immunomodulatory properties of induced pluripotent stem cells (iPSCs) compared with bone marrow-derived mesenchymal stromal cells (MSCs). MATERIALS & METHODS:Mouse embryonic fibroblasts (MEFs) were isolated from C3HeB/FeJ and C57BL/6J mice, and reprogrammed to generate iPSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.29

    authors: Schnabel LV,Abratte CM,Schimenti JC,Felippe MJ,Cassano JM,Southard TL,Cross JA,Fortier LA

    更新日期:2014-01-01 00:00:00

  • In vivo manipulation of stem cells for adipose tissue repair/reconstruction.

    abstract::Many features of adipose stem/progenitor cells, including their physiological functions and localization, have been clarified in the past decade. Adipose tissue turns over very slowly, with perivascular progenitor cells differentiating into new adipocytes to replace dead adipocytes. A number of clinical trials using f...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.62

    authors: Yoshimura K,Eto H,Kato H,Doi K,Aoi N

    更新日期:2011-11-01 00:00:00

  • Cell-based therapy approaches: the hope for incurable diseases.

    abstract::Cell therapies aim to repair the mechanisms underlying disease initiation and progression, achieved through trophic effect or by cell replacement. Multiple cell types can be utilized in such therapies, including stem, progenitor or primary cells. This review covers the current state of cell therapies designed for the ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.14.35

    authors: Buzhor E,Leshansky L,Blumenthal J,Barash H,Warshawsky D,Mazor Y,Shtrichman R

    更新日期:2014-01-01 00:00:00

  • Using poly(lactide-co-glycolide) electrospun scaffolds to deliver cultured epithelial cells to the cornea.

    abstract:AIMS:To assess the potential of electrospun poly(lactide-co-glycolide) membranes to provide a biodegradable cell carrier system for limbal epithelial cells. MATERIAL & METHODS:50:50 poly(lactide-co-glycolide) scaffolds were spun, sterilized and seeded with primary rabbit limbal epithelial cells. Cells were cultured on...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.16

    authors: Deshpande P,McKean R,Blackwood KA,Senior RA,Ogunbanjo A,Ryan AJ,MacNeil S

    更新日期:2010-05-01 00:00:00

  • Early evaluation and value-based pricing of regenerative medicine technologies.

    abstract::Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful m...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.69

    authors: Koerber F,Rolauffs B,Rogowski W

    更新日期:2013-11-01 00:00:00

  • Cell-based therapy for the treatment of female stress urinary incontinence: an early cost-effectiveness analysis.

    abstract:AIM:To perform an early cost-effectiveness analysis of in vitro expanded myoblasts (IVM) and minced myofibers versus midurethral slings (MUS) for surgical treatment of female stress urinary incontinence. METHODS:Cost-effectiveness and sensitivity analyses were performed using a decision tree comprising previously publ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0124

    authors: Vilsbøll AW,Mouritsen JM,Jensen LP,Bødker N,Holst AW,Pennisi CP,Ehlers L

    更新日期:2018-04-01 00:00:00

  • Research progress and prospects of tissue engineering scaffolds for spinal cord injury repair and protection.

    abstract::Spinal cord injury (SCI) is one of the leading causes of global disability. However, there are currently no effective clinical treatments for SCI. Repair of SCI is essential but poses great challenges. As a comprehensive treatment program combining biological scaffolds, seed cells and drugs or biological factors, tiss...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0156

    authors: Ma Z,Lu Y,Yang Y,Wang J,Kang X

    更新日期:2019-09-01 00:00:00